Estimated 2-year PFS2 with 2L BTKi in relapsed/refractory mantle cell lymphoma

Estimate 2-year Mantle Cell Lymphoma PFS2

About

Estimated 2-year PFS2 with 2L BTKi in relapsed/refractory mantle cell lymphoma

References

D. Villa, A. Jiang, N. Crosbie, S. Rule, R. McCulloch et al,

Hematological Oncology: 17 June 2021

By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.

1. MIPI risk category at diagnosis?

0/4 completed